Double Guard Efficiency and Safety—Overcoming Resistance to Immunotherapy by Blocking or Stimulating Several Immune Checkpoints in Non-Small Cell Lung Cancer Patients

SIMPLE SUMMARY: As immunotherapy is one of the leading treatment approaches in non-small cell lung cancer, immunotherapy primary or secondary resistance mechanism need to be deeply understood. Moreover, it is important to know how to avoid or overcome resistance – both have been widely discussed in...

Descripción completa

Detalles Bibliográficos
Autores principales: Kalinka, Ewa, Wojas-Krawczyk, Kamila, Krawczyk, Paweł
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10341137/
https://www.ncbi.nlm.nih.gov/pubmed/37444609
http://dx.doi.org/10.3390/cancers15133499

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10341137/
https://www.ncbi.nlm.nih.gov/pubmed/37444609
http://dx.doi.org/10.3390/cancers15133499

Ejemplares similares